None

None

None

None

A Phase I Trial Multiple Myeloma

A Phase I Trial of Intranasal-API PUSH Trial with Other Site Personal12

MagnetisMM-20 Enrolling people with Multiple Myeloma  

A clinical trial to learn about the effects of combined treatments for multiple myeloma that has returned or not responded to previous treatment 

A Phase 2 Trial of Multiple Myeloma  

A Phase 2 Trial of Multiple Myeloma

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive (DART4MM)

Aim of this study is to evaluate Daratumumab effect on MRD-positive patients with Multiple Myeloma (MM) who achieved >VGPR after any therapy (ASCT, VMP, Rev-Dex). Daratumumab 16 mg/kg administered at weekly intervals for 8 weeks, then every 2 weeks for an additional 16 weeks, will be given to 50 MM …

Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma (MYELOCHOL)

Multiple myeloma (MM) survival has been improved during the last decade owing to new treatments. Hence, it has become a matter of importance to precisely define the depth of MM response to therapy. 18F-FDG PET/CT (FDG-PET) has proved to be superior to X-rays for the initial staging of MM.

end date passed (end date passed)

end date passed